|
Volumn 48, Issue 11, 2001, Pages 1091-1101
|
Preemptive analgesia II: Recent advances and current trends
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADRENALIN;
ALFENTANIL;
ANALGESIC AGENT;
ANESTHETIC AGENT;
BUPIVACAINE;
DICLOFENAC;
FENTANYL;
HALOTHANE;
INDOMETACIN;
ISOFLURANE;
KETAMINE;
LIDOCAINE;
MORPHINE;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;
NAPROXEN;
NEUROTRANSMITTER;
NITROUS OXIDE;
NONSTEROID ANTIINFLAMMATORY AGENT;
OPIATE;
PARACETAMOL;
PIROXICAM;
ROPIVACAINE;
SODIUM CHLORIDE;
THIOPENTAL;
ANESTHESIA LEVEL;
ANTINOCICEPTION;
ARTICLE;
ATTENUATION;
CENTRAL NERVOUS SYSTEM;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
FEMALE;
HUMAN;
HYPERALGESIA;
INDIVIDUALIZATION;
INFLAMMATION;
MALE;
NOCICEPTION;
PERIPHERAL NERVOUS SYSTEM;
POSTOPERATIVE ANALGESIA;
POSTOPERATIVE PAIN;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SENSITIZATION;
SIDE EFFECT;
ANALGESICS, OPIOID;
ANESTHESIA, CONDUCTION;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
EXCITATORY AMINO ACID ANTAGONISTS;
HUMANS;
PAIN, POSTOPERATIVE;
|
EID: 0035569212
PISSN: 0832610X
EISSN: None
Source Type: Journal
DOI: 10.1007/BF03020375 Document Type: Article |
Times cited : (135)
|
References (36)
|